Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Liver

DCEG researchers conduct studies on cancers of the liver, including hepatocellular carcinoma.

Studies include

  • Interferon Lambda 4 (IFNL4) Phenotypes and Risk of Precancer and Cancer

    IFNL4 genotype, including studies of: hepatic inflammation and fibrosis, which are precursors of hepatocellular carcinoma; mucinous ovarian carcinoma; opportunistic infections and malignancies; and neuroinvasive West Nile virus infection. MD: Investigations examining the phenotypic range of IFNL4 genotype, including studies of: hepatic inflammation and fibrosis, which are precursors of hepatocellular carcinoma; mucinous ovarian carcinoma; opportunistic infections and malignancies; and neuroinvasive West Nile virus infection.

  • Liver Cancer Pooling Project

    A liver cancer pooling project among existing U.S. cohorts in order to explore liver cancer etiology in a prospective manner

  • Liver Cancer Research in the Metabolic Epidemiology Branch

    Learn about the research of investigators in the Metabolic Epidemiology Branch on a variety of risk factors for liver cancer, utilizing numerous study populations.

  • The North American Liver Cancer Study

    The North American Liver Cancer Study is a case-control study, in collaboration with the Institute of Nutrition of Central America and Panama, headquartered in Guatemala City, which seeks to increase our understanding of liver cancer risk factors.

Research News

Email